title: Could discontinuing smoking be hazardous for patients administered clozapine medication? A case report.
abstract: A 35-year-old man with schizophrenia was successfully treated with clozapine at a daily oral dose of 700-725 mg for more than 7 consecutive years. Two weeks after abrupt cessation of chronic heavy cigarette smoking, he suddenly developed tonic clonic seizures followed by stupor and coma. After 2 days of intensive care, the patient recovered completely but could not recall the episode. Clozapine therapy was reinstituted and could be carried out successfully at 425 mg daily, i.e., at an approximately 40% reduction of the daily dose before he stopped smoking. The sudden cessation of smoking most likely caused a rise in plasma concentrations of clozapine and/or clozapine metabolites resulting in the seizure episode. A likely mechanism is that the heavy smoking had induced cytochrome P450-1A2, the main enzyme involved in the metabolism of clozapine.
authors.affiliation: Department of Neuroscience and Locomotion, University Hospital, Linköping, Sweden.
authors.forename: E
authors.initials: E
authors.lastname: Skogh
authors.forename: F
authors.initials: F
authors.lastname: Bengtsson
authors.forename: C
authors.initials: C
authors.lastname: Nordin
mesh_terms: D000328:Adult; D003024:Clozapine / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D008297:Male; D012559:Schizophrenia / Q000188:drug therapy*; D012640:Seizures / Q000139:chemically induced*; D016540:Smoking Cessation
chemical_list: D003024:Clozapine